January 10, 2017
With 2016 coming to an end, and in light of new legislation placing greater importance on quality medical translations (Medical Device Regulations, In-Vitro Diagnostic Regulations and CE Marking), I’ve started thinking about lessons from my past experience working in the world of biotech. Before joining the life sciences division, I worked with a nutraceutical startup out of Harlem Biospace where I met numerous vendors with advice, products and services for the life sciences industry. Read more about: Making Informed Life Science Translation Decisions: Quoting Early, Precisely and Often »
January 3, 2017
Arrival, the newest sci-fi alien encounter film to hit the silver screen, promotes an unlikely and yet truly plausible hero. When 12 alien ships unexpectedly arrive on Earth, Dr. Louise Banks, an American translator and expert linguist, is called upon by the U.S. military to help answer the film—and humanity’s—most urgent question: Why are they here? Dr. Banks (played by Amy Adams) becomes the film’s hero when she cracks the code of the aliens’ written language and deduces that their circular smoke-like symbols, Read more about: Arrival: Hollywood’s Newest Hero is a Translator »
December 22, 2016
Online holiday shopping in the US: double-digit YoY growth
Holiday season online retail sales in the US keep growing dramatically from year to year. Cyber Monday online shopping this year hit $3.45 billion, up 12% from last year. And the Cyber Five shopping days (Thanksgiving Day, Black Friday, Cyber Weekend and Cyber Monday) brought in $12.8 billion in online consumer sales.
All in all, holiday season online sales are forecast to exceed $90 billion in the US alone. Read more about: The State of X-Border Online Holiday Shopping »
November 30, 2016
By: Jack Fischer, Business Development Manager – Life Sciences division
The mantra of medical device development is ‘Design, Validate, Iterate – and Repeat’. Unlike large- and small- molecule therapies, the tangible nature of medical devices enables a more efficient path for innovations to reach the market.
For developers, this represents a double-edged sword—the average 510(k) device takes only $73 million to successfully traverse the path from concept to reimbursement. Read more about: Cost-Effective Strategies for Updating Medical Device Documentation »
November 22, 2016
Life science companies – including
medical device, biotech and pharma – are increasingly turning to countries outside the US and W. Europe for clinical trial sites. According to the statistics kept by the National Institutes of Health, almost half of the currently registered studies are being conducted entirely outside of the US and an additional 6% are being conducted both in and outside the US. A more detailed breakdown of the distribution of the non-US multi-regional clinical trial (MRCT) locations indicates that Europe accounts for slightly less than 50% of clinical trials, Read more about: The Critical Role of Language in Global Clinical Trials »